A randomized, double-blind, placebo-controlled, parallel-group study to assess spontaneous morning and nocturnal erections after tadalafil once daily in subjects with erectile dysfunction but naive to phosphodiesterase type 5 inhibitors

被引：0
|
作者：
Moncada, I [1 ]
Kula, K. [2 ]
Barker, C. [3 ]
Kinchen, K. [3 ]
机构：
[1] Hosp La Zarzuela, Aravaca Madrid, Spain
[2] Div Urol, Dept Androl Rep Endocrinol, Lodz, Poland
[3] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
来源：
JOURNAL OF SEXUAL MEDICINE | 2010年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：432 / 432
页数：1
相关论文
共 50 条
  • [41] THE POTENT II DOUBLE-BLIND, RANDOMIZED, PARALLEL-GROUP, PLACEBO-CONTROLLED TRIAL: EFFICACY AND SAFETY OF AN ORODISPERSIBLE (ODT) VARDENAFIL FORMULATION FOR THE TREATMENT OF ERECTILE DYSFUNCTION (ED)
    Gittelman, M.
    McMahon, C. G.
    Rodriguez-Rivera, J. A.
    Beneke, M.
    Ulbrich, E.
    Ewald, S.
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 : 10 - 10
  • [42] Effect of daily ingestion of Bifidobacterium and dietary fiber on vascular endothelial function: a randomized, double-blind, placebo-controlled, parallel-group comparison study
    Azuma, Naoki
    Saito, Yasuo
    Nishijima, Tomohiko
    Aoki, Ryo
    Nishihira, Jun
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2023, 88 (01) : 86 - 96
  • [43] Efficacy and safety of GQ-lab daily in patients with irritable bowel syndrome: A randomized, double-blind, placebo-controlled, parallel-group study
    Shin, C. M.
    Choi, Y. J.
    Yoon, H.
    Park, Y. S.
    Kim, N.
    Lee, D. H.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31
  • [44] Efficacy and Safety of Once-Daily Dosing of Udenafil in the Treatment of Erectile Dysfunction: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
    Zhao, Chen
    Kim, Sae Woong
    Yang, Dae Yul
    Kim, Je Jong
    Park, Nam Cheol
    Lee, Sung Won
    Paick, Jae Seung
    Ahn, Tai Young
    Min, Kweon Sik
    Park, Kwangsung
    Park, Jong Kwan
    EUROPEAN UROLOGY, 2011, 60 (02) : 380 - 387
  • [45] Phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group study of ustekinumab in patients with Takayasu arteritis
    Yoshifuji, Hajime
    Ishii, Tomonori
    Ohashi, Hiroki
    Yoshizawa, Katsunori
    Mihoya, Maki
    Nishikawa, Kazuko
    Nakaoka, Yoshikazu
    RHEUMATOLOGY ADVANCES IN PRACTICE, 2025, 9 (02)
  • [46] A randomized, double-blind, placebo-controlled, multiple-dose, parallel-group clinical trial to assess the effects of teduglutide on gastric emptying of liquids in healthy subjects
    Berg, Jolene Kay
    Kim, Eric H.
    Li, Benjamin
    Joelsson, Bo
    Youssef, Nader N.
    BMC GASTROENTEROLOGY, 2014, 14
  • [47] A randomized, double-blind, placebo-controlled, multiple-dose, parallel-group clinical trial to assess the effects of teduglutide on gastric emptying of liquids in healthy subjects
    Jolene Kay Berg
    Eric H Kim
    Benjamin Li
    Bo Joelsson
    Nader N Youssef
    BMC Gastroenterology, 14
  • [48] Clinical Efficacy of Phosphodiesterase-5 Inhibitor Tadalafil in Eisenmenger Syndrome-A Randomized, Placebo-controlled, Double-blind Crossover Study
    Mukhopadhyay, Saibal
    Nathani, Srikanth
    Yusuf, Jamal
    Shrimal, Devendra
    Tyagi, Sanjay
    CONGENITAL HEART DISEASE, 2011, 6 (05) : 424 - 431
  • [49] Botulinum toxin type A in the prophylactic treatment of chronic tension-type headache:: a multicentre, double-blind, randomized, placebo-controlled, parallel-group study
    Silberstein, SD
    Göbel, H
    Jensen, R
    Elkind, AH
    DeGryse, R
    Walcott, JMCM
    Turkel, C
    CEPHALALGIA, 2006, 26 (07) : 790 - 800
  • [50] Amelioration of bowel movement by daily ingestion of Kumaizasa (Sasa. senanensis) powder: A placebo-controlled, randomized, double-blind, parallel-group comparison study
    Nishihira, Jun
    Hara, Hideo
    Tanaka, Aiko
    Kagami-Katsuyama, Hiroyo
    FUNCTIONAL FOODS IN HEALTH AND DISEASE, 2019, 9 (05): : 341 - 356
12345